-The Hindustan Times By his own admission, Prime Minister Narendra Modi is "happiest" showing the door to laws that are of no use. Accordingly, his government has put in motion a plan to repeal as many as 987 obsolete laws. The law ministry will bring a new bill in the winter session of Parliament to repeal 287 obsolete laws and junk about 700 Appropriation Acts that have lost...

-The Business Standard Make schemes mobile and portable, by focusing on people and not products India spends close to four per cent of its GDP on an alphabet soup of welfare schemes and subsidies - it has become a welfare state before becoming a developed state. Despite its significant costs, India's welfare system is neither comprehensive nor very effective - subject to huge leakages and corruption, and not well knit into...

-The Telegraph New Delhi: A government agency has blocked its own pledge to impose price control on more medicines by withdrawing guidelines that it had used in July this year to cap prices of drugs used to treat diabetes and cardiovascular diseases. The National Pharmaceutical Pricing Authority (NPPA) has withdrawn the guidelines issued under Paragraph 19 of the Drug Price Control Order that it had used in July this year to cap...

-The Business Standard WTO reconvenes to re-examine issue of agriculture subsidies, numbers alone suggest that India has a strong case for declining to sign WTO's TFA The World Trade Organisation (WTO) is reconvening in the last week of September to examine the issue of agricultural subsidies against the backdrop of India's refusal to become a signatory to the trade facilitation agreement (TFA) at Bali. Since then, a lot of water has flowed...

-The Hindu Business Line Fate of 108 drugs brought under price control in July still unclear In a booster for pharmaceutical companies, the Government has ensured that the National Pharmaceutical Pricing Authority (NPPA) no longer enjoys sweeping powers to control drug prices. The NPPA on Tuesday withdrew the guidelines it issued on May 29 that allowed the Authority to control drug prices in public interest. Based on this, it had subsequently capped prices...